Cargando…
Ferumoxytol-enhanced MR imaging for differentiating intrapancreatic splenules from other tumors
OBJECTIVES: Ferumoxytol is an ultra-small superparamagnetic iron oxide (USPIO) agent that is taken up by splenic tissue. This study describes our initial institutional experience of ferumoxytol-enhanced MRI (feMRI) for differentiating intrapancreatic splenules (IPS) from other pancreatic lesions. ME...
Autores principales: | Muehler, M. R., Rendell, V. R., Bergmann, L. L., Winslow, E. R., Reeder, S. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131292/ https://www.ncbi.nlm.nih.gov/pubmed/33377995 http://dx.doi.org/10.1007/s00261-020-02883-y |
Ejemplares similares
-
Incidental intra‐adrenal splenule
por: Lin, Wen‐Hsuan Wendy, et al.
Publicado: (2021) -
Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2020) -
Quantitative MRI of chronic pancreatitis: results from a multi-institutional prospective study, magnetic resonance imaging as a non-invasive method for assessment of pancreatic fibrosis (MINIMAP)
por: Tirkes, Temel, et al.
Publicado: (2022) -
Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case–control study
por: Hoogenboom, Sanne A., et al.
Publicado: (2022) -
Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)